Department of Health and Human Services July 7, 2006 – Federal Register Recent Federal Regulation Documents
Results 1 - 19 of 19
Human-Labeled Drugs Distributed and Used in Animal Medicine; Withdrawal of Compliance Policy Guide
The Food and Drug Administration (FDA) is announcing the withdrawal of a compliance policy guide (CPG) that was issued on March 19, 1991.
Streptomycin Residues in Cattle Tissues; Withdrawal of Compliance Policy Guide
The Food and Drug Administration (FDA) is announcing the withdrawal of the compliance policy guide (CPG) entitled ``Sec. 616.100 Streptomycin Residues in Cattle Tissues (CPG 7125.22).'' This CPG is obsolete.
Protection of Human Subjects: Interpretation of Assurance Requirements
The Office of Public Health and Science, Office of the Secretary, Department of Health and Human Services (HHS) is providing public notice to clarify a requirement contained in the Federalwide Assurance (FWA) form for international (non-U.S.) institutions, approved by the Office for Human Research Protections (OHRP) under the HHS protection of human subjects regulations. HHS clarifies that the requirements of HHS regulations must be satisfied for all HHS-conducted or -supported research covered by an FWA, regardless of whether the research is conducted domestically or internationally. To date, HHS has not deemed any other procedural standards equivalent to the protection of human subjects.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.